Phase I/II study to evaluate penpulimab combined with anlotinib and epirubicin in the first-line treatment of soft tissue sarcoma: Updated.

Yuhong Zhou, Weiqi Lu, Meiyu Fang et al.|Journal of Clinical Oncology|2023

Cited by 1